Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles is a research paper published in Drug Design, Development and Therapy (2026). On theSindex it has a DataRank of 0.292. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R15 CA301437
FWCI
21.64
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals